{"entity":{"type":"insider","cik":"0001374539","url":"/insider/0001374539","json_url":"/insider/0001374539.json","name":"Allen Andrew R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":6,"first":"2011-11-21","last":"2024-05-17","span_basis":"filed_date"},"name_variants":[{"name":"Allen Andrew R","source":"filing","n_filings":6,"first_seen":"2011-11-21","last_seen":"2024-05-17"}],"transactions":[{"id":2278571,"accession":"0001415889-24-013657","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-013657","line_url":"/filing/0001415889-24-013657#line-2","is_derivative":false,"issuer_cik":"0001374539","issuer_name":"Gritstone bio, Inc.","issuer_ticker":"GRTS","issuer_name_source":null,"issuer_url":"/issuer/0001374539","owner_cik":"0001374539","owner_name":"Allen Andrew R","owner_url":"/insider/0001374539","role":"Director, Officer (PRESIDENT AND CEO)","officer_title":"PRESIDENT AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24263.0,"shares_display":"24,263","price_per_share":0.7483,"price_display":"0.75","price_state":"stated","total_value":18156.0029,"total_display":"18,156.00","shares_owned_after":985360.0,"shares_owned_after_display":"985,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-17","scope":"insider"},{"id":6203001,"accession":"0001209191-18-062056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-062056","line_url":"/filing/0001209191-18-062056#line-1","is_derivative":false,"issuer_cik":"0001290149","issuer_name":"Sierra Oncology, Inc.","issuer_ticker":"SRRA","issuer_name_source":null,"issuer_url":"/issuer/0001290149","owner_cik":"0001374539","owner_name":"Allen Andrew R","owner_url":"/insider/0001374539","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":66000.0,"shares_display":"66,000","price_per_share":1.64,"price_display":"1.64","price_state":"stated","total_value":108240.0,"total_display":"108,240.00","shares_owned_after":66000.0,"shares_owned_after_display":"66,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-10","filed_date":"2018-12-11","scope":"insider"},{"id":9269327,"accession":"0001209191-15-005649","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-005649","line_url":"/filing/0001209191-15-005649#line-2","is_derivative":false,"issuer_cik":"0001374539","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001374539","owner_cik":"0001374539","owner_name":"Allen Andrew R","owner_url":"/insider/0001374539","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30524.0,"shares_display":"30,524","price_per_share":65.2675,"price_display":"65.27","price_state":"stated","total_value":1992225.17,"total_display":"1,992,225.17","shares_owned_after":151095.0,"shares_owned_after_display":"151,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-16","filed_date":"2015-01-21","scope":"insider"},{"id":9269326,"accession":"0001209191-15-005649","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-005649","line_url":"/filing/0001209191-15-005649#line-3","is_derivative":false,"issuer_cik":"0001374539","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001374539","owner_cik":"0001374539","owner_name":"Allen Andrew R","owner_url":"/insider/0001374539","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49176.0,"shares_display":"49,176","price_per_share":66.2553,"price_display":"66.26","price_state":"stated","total_value":3258170.6328,"total_display":"3,258,170.63","shares_owned_after":101919.0,"shares_owned_after_display":"101,919","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-16","filed_date":"2015-01-21","scope":"insider"},{"id":8801811,"accession":"0001209191-15-005339","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-005339","line_url":"/filing/0001209191-15-005339#line-3","is_derivative":false,"issuer_cik":"0001374539","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001374539","owner_cik":"0001374539","owner_name":"Allen Andrew R","owner_url":"/insider/0001374539","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49176.0,"shares_display":"49,176","price_per_share":65.877,"price_display":"65.88","price_state":"stated","total_value":3239567.352,"total_display":"3,239,567.35","shares_owned_after":101919.0,"shares_owned_after_display":"101,919","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-16","filed_date":"2015-01-20","scope":"insider"},{"id":8801810,"accession":"0001209191-15-005339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-005339","line_url":"/filing/0001209191-15-005339#line-2","is_derivative":false,"issuer_cik":"0001374539","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001374539","owner_cik":"0001374539","owner_name":"Allen Andrew R","owner_url":"/insider/0001374539","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30524.0,"shares_display":"30,524","price_per_share":65.2675,"price_display":"65.27","price_state":"stated","total_value":1992225.17,"total_display":"1,992,225.17","shares_owned_after":151095.0,"shares_owned_after_display":"151,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-16","filed_date":"2015-01-20","scope":"insider"},{"id":9269328,"accession":"0001209191-15-005649","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-005649","line_url":"/filing/0001209191-15-005649#line-1","is_derivative":false,"issuer_cik":"0001374539","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001374539","owner_cik":"0001374539","owner_name":"Allen Andrew R","owner_url":"/insider/0001374539","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":19500.0,"total_display":"19,500.00","shares_owned_after":181619.0,"shares_owned_after_display":"181,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-15","filed_date":"2015-01-21","scope":"insider"},{"id":8801809,"accession":"0001209191-15-005339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-005339","line_url":"/filing/0001209191-15-005339#line-1","is_derivative":false,"issuer_cik":"0001374539","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001374539","owner_cik":"0001374539","owner_name":"Allen Andrew R","owner_url":"/insider/0001374539","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":19500.0,"total_display":"19,500.00","shares_owned_after":181619.0,"shares_owned_after_display":"181,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-15","filed_date":"2015-01-20","scope":"insider"},{"id":5447380,"accession":"0001181431-13-033603","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-13-033603","line_url":"/filing/0001181431-13-033603#line-6","is_derivative":false,"issuer_cik":"0001374539","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001374539","owner_cik":"0001374539","owner_name":"Allen Andrew R","owner_url":"/insider/0001374539","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6494.0,"shares_display":"6,494","price_per_share":67.65,"price_display":"67.65","price_state":"stated","total_value":439319.1,"total_display":"439,319.10","shares_owned_after":10900.0,"shares_owned_after_display":"10,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-05","filed_date":"2013-06-07","scope":"insider"},{"id":5447377,"accession":"0001181431-13-033603","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-13-033603","line_url":"/filing/0001181431-13-033603#line-5","is_derivative":false,"issuer_cik":"0001374539","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001374539","owner_cik":"0001374539","owner_name":"Allen Andrew R","owner_url":"/insider/0001374539","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5800.0,"shares_display":"5,800","price_per_share":70.06,"price_display":"70.06","price_state":"stated","total_value":406348.0,"total_display":"406,348.00","shares_owned_after":2600.0,"shares_owned_after_display":"2,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-05","filed_date":"2013-06-07","scope":"insider"},{"id":5447374,"accession":"0001181431-13-033603","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-033603","line_url":"/filing/0001181431-13-033603#line-4","is_derivative":false,"issuer_cik":"0001374539","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001374539","owner_cik":"0001374539","owner_name":"Allen Andrew R","owner_url":"/insider/0001374539","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":66.89,"price_display":"66.89","price_state":"stated","total_value":301005.0,"total_display":"301,005.00","shares_owned_after":17394.0,"shares_owned_after_display":"17,394","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-05","filed_date":"2013-06-07","scope":"insider"},{"id":5447371,"accession":"0001181431-13-033603","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-033603","line_url":"/filing/0001181431-13-033603#line-3","is_derivative":false,"issuer_cik":"0001374539","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001374539","owner_cik":"0001374539","owner_name":"Allen Andrew R","owner_url":"/insider/0001374539","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2600.0,"shares_display":"2,600","price_per_share":70.72,"price_display":"70.72","price_state":"stated","total_value":183872.0,"total_display":"183,872.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-05","filed_date":"2013-06-07","scope":"insider"},{"id":5447368,"accession":"0001181431-13-033603","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-033603","line_url":"/filing/0001181431-13-033603#line-2","is_derivative":false,"issuer_cik":"0001374539","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001374539","owner_cik":"0001374539","owner_name":"Allen Andrew R","owner_url":"/insider/0001374539","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":68.84,"price_display":"68.84","price_state":"stated","total_value":172100.0,"total_display":"172,100.00","shares_owned_after":8400.0,"shares_owned_after_display":"8,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-05","filed_date":"2013-06-07","scope":"insider"},{"id":5447364,"accession":"0001181431-13-033603","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-033603","line_url":"/filing/0001181431-13-033603#line-1","is_derivative":false,"issuer_cik":"0001374539","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001374539","owner_cik":"0001374539","owner_name":"Allen Andrew R","owner_url":"/insider/0001374539","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":65.77,"price_display":"65.77","price_state":"stated","total_value":46039.0,"total_display":"46,039.00","shares_owned_after":21894.0,"shares_owned_after_display":"21,894","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-05","filed_date":"2013-06-07","scope":"insider"},{"id":8979036,"accession":"0001209191-11-057329","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-11-057329","line_url":"/filing/0001209191-11-057329#line-5","is_derivative":false,"issuer_cik":"0001374539","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001374539","owner_cik":"0001374539","owner_name":"Allen Andrew R","owner_url":"/insider/0001374539","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3846.0,"shares_display":"3,846","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":49998.0,"total_display":"49,998.00","shares_owned_after":223004.0,"shares_owned_after_display":"223,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-21","filed_date":"2011-11-21","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001656634","name":"Gritstone bio, Inc.","url":"/issuer/0001656634","role":"Director, Officer (PRESIDENT AND CEO)","n_filings":1,"first_seen":"2024-05-17","last_seen":"2024-05-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001290149","name":"Sierra Oncology, Inc.","url":"/issuer/0001290149","role":"Director","n_filings":1,"first_seen":"2018-12-11","last_seen":"2018-12-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001466301","name":"Clovis Oncology, Inc.","url":"/issuer/0001466301","role":"Officer","n_filings":4,"first_seen":"2011-11-21","last_seen":"2015-01-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001374539","retrieved_at":"2026-08-20T23:17:15+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}